These highlights do not include all the information needed to use WEGOVY Manufacturer Novo Nordisk Pharmaceutical Industries, LP | Novo Nordisk A/S - 25a-B Effective date 2026-06-18 Label type HUMAN PRESCRIPTION DRUG LABEL Version 19 Source monthly-update Hydrated at 2026-07-17 21:41:15 Key Label Information# Uses 1 INDICATIONS AND USAGE WEGOVY injection is indicated in combination with a reduced calorie diet and increased physical activity: to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight
Andolfo I, De Falco L, Asci R, Russo R, Colucci S, Gorrese M, et al
It takes only minutes to prepare and its GLP-1 friendly
A serving of brown lentils will pack 12 grams of protein, while a serving of garbanzo beans will provide 7 grams of protein
Retrieved from Luo, J., Feldman, R., Rothenberger, S